Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
14.29
-0.01 (-0.07%)
At close: Jun 27, 2025, 4:00 PM
14.28
-0.01 (-0.07%)
After-hours: Jun 27, 2025, 7:00 PM EDT
Elanco Animal Health Revenue
Elanco Animal Health had revenue of $1.19B in the quarter ending March 31, 2025, a decrease of -1.00%. This brings the company's revenue in the last twelve months to $4.43B, up 1.42% year-over-year. In the year 2024, Elanco Animal Health had annual revenue of $4.44B with 0.50% growth.
Revenue (ttm)
$4.43B
Revenue Growth
+1.42%
P/S Ratio
1.49
Revenue / Employee
$468,466
Employees
9,450
Market Cap
7.10B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.44B | 22.00M | 0.50% |
Dec 31, 2023 | 4.42B | 6.00M | 0.14% |
Dec 31, 2022 | 4.41B | -353.00M | -7.41% |
Dec 31, 2021 | 4.76B | 1.49B | 45.64% |
Dec 31, 2020 | 3.27B | 200.00M | 6.51% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ELAN News
- 1 day ago - Elanco Animal Health Gets Its Bite Back, Pipeline Efforts Earn Praise - Benzinga
- 2 days ago - Elanco Releases 2024 Impact Report and Introduces New Framework - PRNewsWire
- 15 days ago - Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) - PRNewsWire
- 23 days ago - Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief - PRNewsWire
- 4 weeks ago - Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer - PRNewsWire
- 6 weeks ago - Elanco to Participate in the Upcoming Investor Conferences - PRNewsWire
- 6 weeks ago - Elanco: Deleveraging Takes Time - Seeking Alpha
- 7 weeks ago - Elanco Animal Health Incorporated (ELAN) Q1 2025 Earnings Call Transcript - Seeking Alpha